Paper40920573
Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy.
Bruno T and 23 others. Blood, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy. Papers, record 40920573. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40920573
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Multiple Myeloma | Major topic |
| Nuclear Respiratory Factor 1 | Major topic |
| Proteasome Inhibitors | Major topic |
| Bortezomib | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Cell Survival | |
| Cell Line, Tumor | |
| Xenograft Model Antitumor Assays | |
| Enhancer Elements, Genetic | |
| Proteasome Endopeptidase Complex | |
| Gene Expression Regulation, Neoplastic |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 41379498 | Enhancing the targeting of the undruggable. | https://conductscience.org/library/papers/41379498 |
Source PubMed
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19076454 | Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator. | Ann N Y Acad Sci | 2008 | https://conductscience.org/library/papers/19076454 | PubMed |
| 2 | 25838343 | Pathogenesis beyond the cancer clone(s) in multiple myeloma. | Blood | 2015 | https://conductscience.org/library/papers/25838343 | PubMed |
| 3 | 18568025 | IRF4 addiction in multiple myeloma. | Nature | 2008 | https://conductscience.org/library/papers/18568025 | PubMed |
| 4 | 26992692 | Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life study. | J Exp Clin Cancer Res | 2016 | https://conductscience.org/library/papers/26992692 | PubMed |
| 5 | 16728703 | The molecular classification of multiple myeloma. | Blood | 2006 | https://conductscience.org/library/papers/16728703 | PubMed |
| 6 | 20485488 | A large fraction of extragenic RNA pol II transcription sites overlap enhancers. | PLoS Biol | 2010 | https://conductscience.org/library/papers/20485488 | PubMed |
| 7 | 39160255 | Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. | Nat Genet | 2024 | https://conductscience.org/library/papers/39160255 | PubMed |
| 8 | 24097267 | Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. | Nat Methods | 2013 | https://conductscience.org/library/papers/24097267 | PubMed |
| 9 | 17308121 | Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition. | Cancer Res | 2007 | https://conductscience.org/library/papers/17308121 | PubMed |
| 10 | 38514625 | Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma. | Nat Commun | 2024 | https://conductscience.org/library/papers/38514625 | PubMed |
| 11 | 32848148 | ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation. | Nat Commun | 2020 | https://conductscience.org/library/papers/32848148 | PubMed |
| 12 | 33007258 | A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer. | Cancer Cell | 2020 | https://conductscience.org/library/papers/33007258 | PubMed |
| 13 | 23729400 | Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myeloma. | Mol Cancer Ther | 2013 | https://conductscience.org/library/papers/23729400 | PubMed |
| 14 | 19451168 | Fast and accurate short read alignment with Burrows-Wheeler transform. | Bioinformatics | 2009 | https://conductscience.org/library/papers/19451168 | PubMed |
| 15 | 30245231 | Drug resistance in multiple myeloma. | Cancer Treat Rev | 2018 | https://conductscience.org/library/papers/30245231 | PubMed |
| 16 | 22645181 | Proteasome inhibitors in multiple myeloma: 10 years later. | Blood | 2012 | https://conductscience.org/library/papers/22645181 | PubMed |
| 17 | 20639541 | BigWig and BigBed: enabling browsing of large distributed datasets. | Bioinformatics | 2010 | https://conductscience.org/library/papers/20639541 | PubMed |
| 18 | 21441462 | Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies. | Blood | 2011 | https://conductscience.org/library/papers/21441462 | PubMed |
| 19 | 8808631 | Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly. | Cell | 1996 | https://conductscience.org/library/papers/8808631 | PubMed |
| 20 | 8253388 | NRF-1, an activator involved in nuclear-mitochondrial interactions, utilizes a new DNA-binding domain conserved in a family of developmental regulators. | Genes Dev | 1993 | https://conductscience.org/library/papers/8253388 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41776655 | Challenges and advances in drug resistance and tolerance in cancer. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/41776655 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NRF1 | 4899 | PubTator's text mining | https://conductscience.org/library/genes/4899 | NCBI Gene |
| SDC1 | 6382 | PubTator's text mining | https://conductscience.org/library/genes/6382 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40920573
GET https://conductscience.org/api/papers/v1/40920573/authors?page=2